Valeant drops name in bid to break with past
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Bausch Health Companies will be the new name for Canada’s Valeant Pharmaceuticals International from 1 July 2018. The name – which is taken from the firm’s Bausch + Lomb eye-care business – “accurately represents the breadth of the company today”, according to Valeant, “and reflects the innovative legacy of the Bausch business”.